Arsenic trioxide and all-trans retinoic acid suppress the expression of FLT3-ITD
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Arsenic trioxide and all-trans retinoic acid suppress the expression of FLT3-ITD
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume -, Issue -, Pages 1-8
Publisher
Informa UK Limited
Online
2020-06-14
DOI
10.1080/10428194.2020.1775212
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Midostaurin added to chemotherapy and continued single agent maintenance therapy in acute myeloid leukemia with FLT3-ITD
- (2018) Richard F. Schlenk et al. BLOOD
- Arsenic trioxide and all-trans-retinoic acid selectively exert synergistic cytotoxicity against FLT3-ITD AML cells via co-inhibition of FLT3 signaling pathways
- (2017) Li-Na Wang et al. LEUKEMIA & LYMPHOMA
- Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells
- (2015) C. Larrue et al. BLOOD
- Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RAR and PLZF-RAR -Driven Leukemia
- (2015) N. Coltella et al. CLINICAL CANCER RESEARCH
- FLT3-ITD in acute promyelocytic leukemia: Clinical distinct profile but still controversial prognosis
- (2015) Matteo Molica et al. LEUKEMIA RESEARCH
- Molecular therapy for acute myeloid leukaemia
- (2015) Catherine C. Coombs et al. Nature Reviews Clinical Oncology
- Incorporation of arsenic trioxide in induction therapy improves survival of patients with newly diagnosed acute promyelocytic leukaemia
- (2014) Xianmin Song et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531
- (2014) Alan S. Gamis et al. JOURNAL OF CLINICAL ONCOLOGY
- Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia
- (2013) Guilherme Augusto dos Santos et al. JOURNAL OF EXPERIMENTAL MEDICINE
- FLT3tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitations
- (2013) Sabine Kayser et al. LEUKEMIA & LYMPHOMA
- Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia
- (2012) W. Blum et al. BLOOD
- Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia
- (2011) A. Staffas et al. BLOOD
- Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia
- (2011) H. Iland et al. HAEMATOLOGICA
- Ubiquitin conjugase UBCH8 targets active FMS-like tyrosine kinase 3 for proteasomal degradation
- (2010) M Buchwald et al. LEUKEMIA
- Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: A systematic review
- (2010) Amer Beitinjaneh et al. LEUKEMIA RESEARCH
- Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
- (2009) J. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now